(VRCA) |
| 0 (0%) 09-16 04:18 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 5.86 |
| Resistance 1: | 5.36 |
| Pivot price: | 5.13 |
| Support 1: | 4.56 |
| Support 2: | 3.79 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -1.740 |
| Book Value | 0.250 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.665 |
| Profit Margin (%) | -102.84 |
| Operating Margin (%) | -194.46 |
| Return on Assets (ttm) | -44.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Mon, 14 Sep 2026
VRCA: Phase III programs for common warts and BCC advance rapidly, with strong efficacy and global expansion - TradingView
Fri, 11 Sep 2026
Number of shareholders of Verrica Pharmaceuticals Inc. – NASDAQ:VRCA - TradingView
Tue, 08 Sep 2026
A contagious skin infection affects about 6 million, mostly children. Verrica presents Sept. 14. - Stock Titan
Tue, 08 Sep 2026
Discipline and Rules-Based Execution in VRCA Response - Stock Traders Daily
Sat, 05 Sep 2026
Verrica Pharmaceuticals Stock Price Forecast. Should You Buy VRCA? - StockInvest.us
Fri, 04 Sep 2026
VRCA News | VERRICA PHARMACEUTICALS INC (NASDAQ:VRCA) - ChartMill
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
